About Us

MyndTec is committed to the development and commercialization of pioneering neurotechnology products that enhance function, foster independence, and improve the quality of life for individuals affected by neurological disorders, chronic pain, and central nervous system injuries, including conditions resulting from stroke and spinal cord injury (SCI). Through advanced neuroimaging, neuromodulation, and regenerative therapies, the Company addresses both invasive and non-invasive therapeutic needs, specifically targeting large and expanding global patient populations.

Recognizing the critical gap in predictive healthcare solutions, the Company is dedicated to integrating machine learning and AI-enabled technologies to deliver data-driven, predictive insights that significantly improve patient outcomes. By embedding these advanced technologies, the Company aims to optimize resource use at the individual, corporate, and healthcare system levels, ultimately enhancing patient care, streamlining decision-making, and maximizing the efficiency of healthcare delivery.

Mission

MyndTec’s mission is to revolutionize the treatment of brain disorders by progressing from neuromodulation to regenerative therapies. Through cutting-edge research, brain imaging, and personalized approaches, we aim to restore patient independence and deliver lasting, transformative health outcomes.

Vision

Our vision is to lead the future of neurological care by advancing from neuromodulation to regenerative health solutions. MyndTec strives to enhance patient outcomes through innovative, precision-based treatments, and build strategic partnerships that bring these groundbreaking, life-changing therapies to both patients and healthcare providers.